Welcome to our dedicated page for BOWHEAD SPECIALTY HLDGS SEC filings (Ticker: BOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bowhead Specialty Holdings Inc. (NYSE: BOW) SEC filings page brings together the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. As a specialty property and casualty insurance group, Bowhead Specialty uses its SEC reports to disclose underwriting performance, capital structure, governance matters and material agreements.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed information on gross written premiums by division, net earned premiums, loss and expense ratios, combined ratios, reinsurance arrangements and the composition of the investment portfolio. These filings also describe risk factors, capital management, reserves for losses and loss adjustment expenses, and other topics that are central to a specialty insurer’s financial profile.
Bowhead Specialty’s current reports on Form 8-K provide timely disclosure of specific events. Recent 8-K filings describe the completion of a public offering of 7.750% Senior Notes due 2030, the intended use of proceeds to fund capital contributions to an insurance subsidiary and other corporate purposes, the entry into a senior secured revolving credit facility, and the repayment and termination of a prior credit agreement. Other 8-Ks cover quarterly earnings press releases, investor presentations, secondary offerings of common stock by an existing stockholder, and changes to the board of directors and board committees.
On this page, users can also access S-3 shelf registration statements, prospectus supplements and related documents referenced in Bowhead Specialty’s capital markets transactions, as well as proxy materials and governance filings. Stock Titan enhances these filings with AI-powered summaries that explain key terms, highlight important covenants and capital metrics, and clarify how items such as senior notes, credit facilities and non-GAAP measures relate to the company’s overall financial position. Real-time updates from EDGAR help ensure that new Bowhead Specialty filings, including Forms 3, 4 and 5 for insider transactions when available, are quickly reflected for further analysis.
Bowhead Specialty Holdings Inc. received a Schedule 13G reporting that American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research beneficially own 1,827,525 shares of Bowhead common stock, representing 5.6% of the class as of December 31, 2025.
The filing shows sole voting power over 1,625,459 shares and sole dispositive power over 1,827,525 shares. The securities are reported as being held in the ordinary course of business, not for the purpose of changing or influencing control of Bowhead.
Bowhead Specialty Holdings Inc. director reported acquiring additional common stock in the company. On May 1, 2025, the reporting person acquired 4,038 shares of common stock at a stated price of $0, bringing their directly held beneficial ownership to 36,773 shares after the transaction.
The footnotes explain that this total includes 23,324 shares of common stock that were previously received on September 19, 2024 for no consideration, as part of a pro rata distribution connected to the dissolution of Bowhead Insurance Holdings LP. That earlier acquisition was treated as exempt from reporting under Rule 16a-9 of the Securities Exchange Act of 1934.
Bowhead Specialty Holdings Inc. entered into a new senior secured revolving credit facility of
The revolving credit facility matures on the earlier of November 26, 2027 or a date tied to the potential termination of certain MGA agreements, and is secured by a first-priority lien on substantially all of the company’s assets. Borrowings will bear interest at either a Term SOFR-based rate plus a
Bowhead Specialty Holdings Inc. (BOW) CEO, President and Director Stephen J. Sills reported an internal transfer of company stock. On 11/26/2025, he moved 75,000 shares of common stock in a transaction coded "G" (a gift or similar transfer) at a price of $0 per share from his direct holdings to the Stephen J. Sills 2024 I GRAT #4 grantor trust. After this transfer, he directly held 786,000 shares and also reported additional indirect ownership through several trusts and an LLC, including the new 75,000-share position in the GRAT.
Bowhead Specialty Holdings Inc. completed a public offering of $150,000,000 aggregate principal amount of its 7.750% Senior Notes due 2030. These senior, unsecured notes were issued under an existing shelf registration and will bear interest at 7.750% per year, paid semi-annually starting June 1, 2026, with final maturity on December 1, 2030, unless earlier repurchased or redeemed.
The company plans to use the net proceeds primarily to make capital contributions to its insurance subsidiary to support business growth and for other general corporate purposes. At the same time, Bowhead Specialty repaid in full and terminated all outstanding indebtedness and obligations under its prior credit agreement, and all related security interests and guarantees were released.
Bowhead Specialty Holdings Inc. is offering $150,000,000 of 7.750% senior notes due 2030 at 100% of principal, with semi-annual interest payments starting June 1, 2026. These senior unsecured notes rank equally with Bowhead’s other unsubordinated debt and are structurally subordinated to the liabilities and preferred equity of its subsidiaries, including $1.1 billion of policyholder and contract-holder liabilities as of September 30, 2025. The notes may be redeemed early at a make-whole premium before December 1, 2028 and at specified premiums thereafter. Bowhead expects net proceeds of about $146.4 million, which it plans to use to repay an existing credit agreement, contribute capital to its insurance subsidiary to support growth, and for other general corporate purposes.
Bowhead Specialty Holdings Inc. plans an underwritten public offering of senior unsecured notes due 2030. The notes will pay fixed semi-annual interest, with the coupon subject to a step-up of up to 1.00% if their credit rating from a designated agency falls below investment grade or is withdrawn. The notes rank equally with Bowhead’s other unsecured debt but are effectively junior to any future secured borrowings and structurally subordinated to obligations of its insurance subsidiaries, which had $1.1 billion in liabilities to policyholders and contract holders as of September 30, 2025.
Bowhead intends to use the net proceeds to make capital contributions to its insurance company subsidiary to support growth and for general corporate purposes, and expects to repay and terminate its existing credit agreement around the time of closing. The company also plans to enter into a new senior secured revolving credit facility of up to $35.0 million after the offering. The notes may be redeemed early at specified premiums and carry financial covenants limiting consolidated indebtedness relative to capitalization and restricting secured debt.
Bowhead Specialty Holdings (BOW): Schedule 13G/A reports that GPC Partners Investments (SPV III) LP, together with affiliated reporting persons, beneficially owns 8,968,445 shares of common stock, representing 27.4% of the class. The filing states sole voting and sole dispositive power over the same 8,968,445 shares for each reporting person listed, with no shared power disclosed.
The percentage was calculated using 32,782,974 shares outstanding as of September 30, 2025, as disclosed by the issuer. The reporting group includes GPC Partners GP LLC, Gallatin Point Capital LLC, and individuals Matthew B. Botein and Lewis A. (Lee) Sachs. The filing notes a Voting Agreement dated May 22, 2024 between GPC Fund and American Family Mutual Insurance Company, S.I.; each reporting person disclaims beneficial ownership of any shares held by AFMIC.
Bowhead Specialty Holdings (BOW) reported stronger Q3 2025 results. Net income was $15.2 million versus $12.1 million a year ago, and diluted EPS was $0.45 versus $0.36. Growth was supported by higher underwriting volume and investment income.
Gross written premiums were $231.5 million (up from $197.0 million), and net earned premiums were $128.4 million (up from $105.2 million). Net investment income rose to $15.0 million from $11.5 million. Total revenues reached $143.9 million versus $116.8 million, while total expenses were $124.8 million versus $100.9 million.
The balance sheet expanded: total assets were $2.09 billion and stockholders’ equity was $430.2 million. Cash and cash equivalents were $197.9 million, with restricted cash of $52.9 million. Fixed maturity securities at fair value were $1.15 billion. The company had no borrowings under its $75 million senior secured revolving credit facility as of September 30, 2025. Shares outstanding were 32,782,974 as of October 29, 2025.
Bowhead Specialty Holdings Inc. reported that it issued a press release announcing its financial results for the three months ended September 30, 2025. The company also released an investor presentation covering the same period.
Both materials were furnished with this report as Exhibit 99.1 (press release) and Exhibit 99.2 (presentation) and are available on the company’s investor relations website. This filing is an informational update; it does not detail the underlying results.
FAQ
What is the current stock price of BOWHEAD SPECIALTY HLDGS (BOW)?
What is the market cap of BOWHEAD SPECIALTY HLDGS (BOW)?
